Risk assessment for human developmental neurotoxicity (WP6)

Pre- postnatal Screening exposure tools for assessment & neurotoxicity neuro- hazard (WP2) development (WP4)

Epidemiology: Timing of exposure in validation genomic, behaviour, cognitive proteomic, and motor function metabolomic markers assessment (WP3) (WP5)

Biomarkers for (developmental) neurotoxicity

Figure 1: Work packages of DENAMIC.

List of beneficiaries DENAMIC. Partner Country Contact person VU Univeristy The Netherlands Pim Leonards IRAS, University Utrecht (IRAS) The Netherlands Milou Dingemans Uppsala University (UU) Sweden Per Eriksson, Henrik Viberg Fundacion de La Comunidad Valenciana Spain Vicente Felipo Centro de Investigacion Principe Felipe (CIPF) Slovak Medical University (SMU) Slovakia Lubica Palkovicova Murinova Callisto Productions Ltd United Kingdom Tom McInnes Center for Public Health Research Spain Marisa Rebagliato Norwegian Institute of Public Health Norway Merete Eggesbø Instituto de Medicina Genomica Spain Javier Garcia-Planells Viewpoint France Didier Neuzeret Proteome Sciences plc United Kingdom Stephan Jung, Ian Pike Institutul National De Cercetare-Dezvoltare Romenia Raluca-Ioana Stefan-van Staden Pentru Electrochimie Si Materie Condensata - INCEMC Gen info Ltd Croatia Ozren Polašek Masarykova Univerzita Czech Republic Anton Kocan

DENAMIC film “Young minds at risk?

Youtube: https://youtu.be/drcOBcA2mD0

Table 1: List of chemicals studied in DENAMIC.

6-OH-BDE47 -ethyl DEHP paraoxon-methyl PBDE PCB PFHxS PFOA flubendiamide PFOS chlorpyrifos- hexachlorobenzene TCPP MeHg MEHP TOCP DDD methoate DDE DDT